PDLLA3000-mPEG2000, PDI≤1.25

PDLLA3000-mPEG2000, PDI≤1.25, combined with d-α-tocopherol acid of polyethylene glycol succinat (TPGs), forms a homogeneous, stable spherical micellar system with a particle size of 67.42 nm, PDI of 0.229, and zeta potential of -18.67 mV when used to fabricate Hyperoside (HY-N0452)-loaded micelles via thin film dispersion^[1].
PDLLA3000-mPEG2000, PDI≤1.25 (0.1-10 μg/mL; 12 h dark incubation), combined with TPGs, forms blank micelles with a critical micelle concentration of 2.56 μg/mL, indicating excellent self-assembly capability and stability^[1].
PDLLA3000-mPEG2000, PDI≤1.25 (10-200 μg/mL; 48 h), combined with TPGs, forms blank micelles that exhibit low cytotoxicity^[1].
PDLLA3000-mPEG2000, PDI≤1.25 forms stable spherical nanomicelles with glucose-Paclitaxel (HY-B0015), achieving a high encapsulation efficiency of 95.59% and drug loading of 11.46%, with no significant changes in size or zeta potential over 28 days of storage at 25°C or 4°C^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.